Lanthanum Carbonate Versus Calcium Carbonate for Vascular Abnormalities in Patients With Chronic Kidney Disease and Hyperphosphatemia
Phase of Trial: Phase IV
Latest Information Update: 16 Jan 2019
Price : $35 *
At a glance
- Drugs Lanthanum carbonate (Primary) ; Calcium carbonate
- Indications Hyperphosphataemia; Renal failure
- Focus Therapeutic Use
- Acronyms LAVALIER
- 31 Aug 2018 Biomarkers information updated
- 29 Aug 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2020.
- 26 Sep 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.